TXNDC5 and COVID-19: Other studies have identified an upregulation of TXNDC5 in Parkinson’s disease, respiratory distress syndrome following cardiopulmonary bypass, COVID-19, malaria, Salmonella enteritidis and Marek’s disease infection [199,200,201,202,203,204].